FDA Panel Votes Against Pfizer’s COVID Booster for Everyone, Recommends It for People 65 and Older

Contact Your Elected Officials
The Epoch Times Logo

The U.S. Food and Drug Administration’s vaccine advisory panel on Friday voted 16–3 to recommend against providing booster shots of the Pfizer COVID-19 vaccine for individuals aged 16 and older. The panel later voted to endorse the Pfizer booster for individuals who are aged 65 and older and for those who are at high risk.

Throughout the meeting, independent scientists who advise the Food and Drug Administration (FDA) struck a skeptical tone on the need for boosters, or third doses, for Pfizer’s COVID-19 vaccine for the general public. The advisory panel’s discussion is the first major test for the Biden administration’s vaccination agenda as top health officials last month announced they would try to roll out boosters for everyone by Sept. 20.

But for people aged 65 and older and those at high risk of occupational exposure, booster doses were recommended in an 18–0 vote.

It’s not clear when a final FDA decision could come on booster doses, while the Centers for Disease Control and Prevention (CDC) has scheduled a meeting next week to distribute boosters around the United States. The Epoch Times has contacted the FDA for comment.

“We are not bound at FDA by your vote, just so you understand that. We can tweak this as need be,” Dr. Peter Marks, the agency’s top vaccine official, said after the votes were cast.

In a statement following the vote, a White House spokesman said: “Today was an important step forward in providing better protection to Americans from COVID-19. We stand ready to provide booster shots to eligible Americans once the process concludes at the end of next week.”

While U.S. health officials, some other countries, and vaccine makers have argued that boosters are needed for everyone, many scientists, including some inside the FDA and the CDC, have disagreed. Booster doses have been previously recommended by the CDC for immunocompromised individuals.

But an FDA slide said the risk of COVID-19 for a healthy 30-year-old is just 0.0004 percent, or 1 in 250,000, bolstering arguments against boosters being recommended for the general population. Some recommended a booster for older individuals but several experts said they want more data about whether the booster shots can contribute to myocarditis, a type of heart inflammation.

Dr. James Hildreth, a voting member on the FDA expert panel, said that he “[has] a serious concern of myocarditis in young people.” The FDA previously issued warnings that, while rare, Pfizer and Moderna vaccines, both of which are built on messenger RNA technology, could cause myocarditis or pericarditis among younger individuals.

“I honestly don’t think there is enough good quality data at this point to make an informed decision,” Brittany Kmush, an epidemiologist at Syracuse University, said of the Israeli study, noting the 12-day follow-up period and the variability of the authors’ estimates.

Another FDA advisor, Dr. Melinda Wharton, meanwhile, echoed Hildreth’s concerns and said she would “not feel comfortable” with recommending boosters to younger people due to the risk of myocarditis. Younger people are not at risk of developing severe illness from COVID-19 or becoming severe breakthrough cases, she noted during the panel.

Earlier this week, the FDA uploaded Pfizer’s arguments that cited studies in Israel and the United States suggesting that the COVID-19 vaccine’s efficacy drops over time and said that booster doses are necessary to deal with new variants of the CCP (Chinese Communist Party) virus, which causes COVID-19.

By Jack Phillips

Read Full Article on TheEpochTimes.com

FDA Panel Votes 16–3 Against Approving Pfizer COVID-19 Booster Shots

The U.S. Food and Drug Administration (FDA) advisory panel on Friday voted 16-3 to recommended against providing booster shots of the Pfizer COVID-19 vaccine for individuals aged 16 and older.

Throughout the meeting, independent scientists to the FDA struck a skeptical tone on the need for boosters, or third doses, for Pfizer’s mRNA COVID-19 vaccine for the general public. The advisory panel’s discussion is the first major test for the Biden administration’s vaccination agenda as top health officials last month announced they would try to roll out boosters for everyone by Sept. 20.

While U.S. health officials, some other countries and vaccine makers have argued that boosters are needed, many scientists, including some inside the FDA and the U.S. Centers for Disease Control and Prevention (CDC), have disagreed. Booster doses have been previously recommended by the CDC for immunocompromised individuals.

But to boost arguments against boosters being recommended for the general population, an FDA slide said the risk of COVID-19 for a or healthy 30-year-old is just 0.0004 percent, or 1 in 250,000. Some recommended a booster for older individuals but several experts said they want more data about whether the booster shots can contributed to myocarditis.

Dr. James Hildreth, a voting member on the FDA expert panel, said that he “[has] a serious concern of myocarditis in young people,” referring to a type of heart inflammation. The FDA previously issued warnings that while rare, Pfizer and Moderna vaccines could cause myocarditis among younger individuals.

“I honestly don’t think there is enough good quality data at this point to make an informed decision,” Brittany Kmush, an epidemiologist at Syracuse University, said of the Israeli study, noting the 12-day follow-up period and the variability of the authors’ estimates.

And another FDA advisor, Dr. Melinda Wharton, meanwhile, echoed Hildreth’s concerns and said she would “not feel comfortable” with recommending boosters to younger people due to the risk of myocarditis. Younger people are not at risk of developing severe illness from COVID-19 or becoming severe breakthrough cases, she noted during the panel.

Earlier this week, the FDA uploaded Pfizer’s arguments that cited studies in Israel and the United States suggesting that the COVID-19 vaccine’s efficacy drops over time and said that booster doses are necessary to deal with new virus variants.

By Jack Phillips

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

250 Countdown

Those 56 intrepid men who signed put their very lives, honor and fortunes on the line. There was no auto-quill to accommodate their signatures. 

How the Senate Parliamentarian Changed the OBBB

An unelected bureaucrat does a important job in the U.S. Senate. Elizabeth MacDonough enforces senate rules on Trump’s “One Big Beautiful Bill”.

Bioterror Roundup: CDC Director Nominee Is a Monster + New mRNA Pregnancy Studies

Bioterror Propaganda Roundup: The latest updates on the “new...

The Sacred Honor of the 56

Today we're celebrating the sacred honor of the 56 men who signed the Declaration of Independence.

Alligator Alcatraz: A Bold Step Toward Secure Borders

Alligator Alcatraz funded through FEMA, represents a decisive move by the Trump admin to address illegal immigration with efficiency and resolve.

New White House Faith Office Aims to Ensure US Is Beacon of Freedom for Others

The White House Faith Office wants to see the United States as the leader in advancing religious freedom, its faith director Jennifer Korn said.

Federal Reserve Rates Are Too High, Says Former World Bank Chief

Rates should be between 0.25 and 1.75 percent rather...

Newly Naturalized Citizens Say What American Freedom Means to Them

Nearly 820,000 people pledged allegiance to the United States and became naturalized citizens in 2024.

Noem Waives Environmental Restrictions to Fast-Track Water Barriers in Rio Grande

DHS Sec Kristi Noem waived federal environmental laws to fast-track construction of 17 miles of waterborne barriers in the Rio Grande in South Texas.

Trump Indicates Legislation for Hiring Illegal Aliens on Farms

Trump to allow illegal immigrants who work on farms to continue working to prevent unnecessary disruptions to farming across the country.

US Keeps Pressure on Chinese Goods Amid Vietnam Trade Deal

Transshipping—rerouting goods through a third country to disguise the origin of the products—is a focal point of trade negotiations with Asian markets.

White House Report Reveals Top Earners, Staffers Working for No Salary

The Trump admin released its yearly report that shows the salaries for White House staffers, also revealing officials who aren’t accepting salaries at all.

Transportation Secretary Urges Governors to Remove Political Messages From Crosswalks, Intersections

Duffy sent letters to governors, mayor of D.C., and gov of Puerto Rico urging them to remove political messaging from intersections and crosswalks.
spot_img

Related Articles